jain.com

Transition to US domestic issuer status from July 1, 2025

Company: IREN

Subject kind
regulatory
Statement date
2025-06-04
Promised by
2025-07-01
Current status
outcome unconfirmed

What the later record shows

Outcome not yet confirmed

No passage text states the change in status. However, IREN's later documents are a 10-K, 10-Qs and a DEF 14A, which are US domestic filer forms, so the transition appears to have occurred. The exact start date is not confirmed in text.

Checked October 13, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

IREN is transitioning from foreign private issuer to US domestic issuer status from July 1, 2025.

Source (primary)

iren 8-K exhibit (ex991may2025monthlyupdat.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-13)Live source ↗

Quote: “Transitioning to US domestic issuer status from July 1”

How we checked this

Checked on October 15, 2026. The cited source supports every part of this claim.

The June 2025 update says IREN is transitioning to US domestic issuer status from July 1, and its risk disclosures describe IREN ceasing to be a foreign private issuer.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1878848/000187884825000045/ex991may2025monthlyupdat.htm) in full (23,643 characters, retrieved October 13, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms iren 8-K exhibit (ex991may2025monthlyupdat.htm)

Quote: “Transitioning to US domestic issuer status from July 1”

View cached copy (2026-10-13)Live source ↗

Record of changes

October 13, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 13, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.